KellyAnn D. Pryor - Concepedia

Author

KellyAnn D. Pryor

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

K. D. Pryor, K. Pryor, KellyAnn D. PRYOR, KellyAnn D. Pryor, Kellyann D. Pryor, Kellyann Pryor

Publications

820

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

KellyAnn D. Pryor is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	439
2	Biochemistry	8	8	626
3	Natural Sciences	6	6	561
4	Health Sciences	1	1	48
5	Biomolecular Engineering	1	1	16

KellyAnn D. Pryor

Publications

814

Citations

H-Index

Page 1

	Year	Citations
High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion System KellyAnn D. Pryor, Barbara Leiting Protein Expression and Purification Protein ChemistrySoluble ProteinProtein ExpressionBiochemistryProtein Assembly	1997	244
Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII Barbara Leiting, KellyAnn D. Pryor, Joseph K. Wu, Biochemical Journal Proteomic TechnologyMolecular PharmacologyCatalytic ConstantsProtein FunctionGlucagon Family Peptides	2003	181
Discovery of Potent and Selective Dipeptidyl Peptidase IV Inhibitors Derived from β-Aminoamides Bearing Subsituted Triazolopiperazines Dooseop Kim, Jennifer E. Kowalchick, Linda Brockunier, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical SciencePharmaceutical ChemistryPharmacological Study	2008	60
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: Close analogs of JANUVIA™ (sitagliptin phosphate) Dooseop Kim, Jennifer E. Kowalchick, Scott D. Edmondson, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceClose AnalogsMedicine	2007	57
Design and Synthesis of Prolylcarboxypeptidase (PrCP) Inhibitors To Validate PrCP As A Potential Target for Obesity Changyou Zhou, Margareta Garcia-Calvo, Shirly Pinto, Journal of Medicinal Chemistry	2010	51
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses Kalpit A. Vora, Gene Porter, Roche Peng, BMC Immunology	2009	49
Inhibition of IMP-1 metallo-Î²-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives Gail G. Hammond, Joann Huber, Mark L. Greenlee, FEMS Microbiology Letters Thioester DerivativesBioorganic ChemistryEscherichia ColiAntibiotic ResistanceBacterial Pathogens	1999	48
Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors Jennifer E. Kowalchick, Barbara Leiting, KellyAnn D. Pryor, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryTriazolopiperazine-based β-Amino AmidesMedicine	2007	44
One-Day Enzymatic Synthesis and Purification of UDP–N- [1-14C]Acetyl-Glucosamine Barbara Leiting, KellyAnn D. Pryor, Suzanne S. Eveland, Analytical Biochemistry One-day Enzymatic SynthesisBiochemistryGlycobiologyNatural Product SynthesisEnzymatic Modification	1998	17
Inhibition of Dipeptidyl-Peptidase IV Does Not Increase Circulating IGF-1 Concentrations in Growing Pigs Terry D. Faidley, Barbara Leiting, KellyAnn D. Pryor, Experimental Biology and Medicine Animal PhysiologyPlasma ConcentrationsGrowth HormoneDipeptidyl-peptidase Iv DoesAnimal Science	2006	17

Page 1